GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...
"Amyloid-lowering treatments represent an important advance in the treatment of Alzheimer's disease but they are associated ...
QuantalX Neuroscience Ltd. is proud to announce that its Delphi-MD (Direct Electrophysiological Imaging Device), an ...
News Medical on MSN6d
Traditional Chinese herb shows promise against Alzheimer’s and Parkinson’sZizyphi spinosi semen demonstrates neuroprotective effects, improving cognitive function and reducing amyloid and tau pathology in models of aging and dementia.
The Iowa Chapter of the American Parkinson Disease Association is holding a Parkinson education program from 1 to 3:30 p.m. Wednesday at the Fort Dodge Public Library, 424 Central Ave. The event is ...
What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...
Austin, Nov. 11, 2024 (GLOBE NEWSWIRE) --“According to S&S Insider, The Neuroscience Market Size was valued at USD 35.3 ...
Good afternoon and welcome to today's conference call for Omeros Corporation. (Operator Instructions) Please be advised that this call is being recorded at the company's request and a replay will be ...
MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for ...
MintNeuro, a pioneer of scalable, low-power semiconductor technology for minimally-invasive neural implant applications, today announces that it has raised £1 million in a funding round led by ...
In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback